mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
6e-05 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.2 |
0.0006 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |